PRAX Q1 2025 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$61M

Operating Income

-$75M

Net Income

-$69M

EPS (Diluted)

$-3.29

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$53M

Free Cash Flow

-$53M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$479M

Total Liabilities

$40M

Stockholders' Equity

$439M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$431,000	-100.0%
Gross Profit	-$61M	-$27M	-129.0%
Operating Income	-$75M	-$42M	-78.4%
Net Income	-$69M	-$40M	-75.2%